No correlation between side-chain of propranolol oxidation and S-mephenytoin 4'-hydroxylase activity

Acta Pharmacologica Sinica

Volumn 18, Issue 3, 1997, Pages 216-218

  Xie, Hong Guang ^a   Xu, Zhen Hua ^a   Huang, Song Lin ^a   Liu, Jin Hua ^b   Wu, Jin Xiang ^a   Jiang, Chang Hong ^a   Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

cytochrome P 450; hydroxylases; mephenytoin; pharmacogenetics; pharmacokinetics; propranolol

Indexed keywords

4' HYDROXYMEPHENYTOIN; CYTOCHROME P450 ISOENZYME; DRUG METABOLITE; MEPHENYTOIN; NAPHTHOXYLACETIC ACID; OXYGENASE; PROPRANOLOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG OXIDATION; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOGENETICS; RACEMIC MIXTURE;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MALE; MEPHENYTOIN; MIXED FUNCTION OXYGENASES; OXIDATION-REDUCTION; PROPRANOLOL;

EID: 0030996734     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Walle T, Walle UK, Olanoff LS. Quantitative account of propranolol metabolism in urine of normal man. Drug Metab Dispos 1985; 13: 204-9.
2. Ward SA, Walle T, Walle UK, Wilkinson GR, Branch RA. Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. Clin Pharmacol Ther 1989; 45: 72-9.
3. Otton SV, Gillam EMJ, Lennard MS, Tucker GT, Woods HF. Propranolol oxidation by human liver microsomes: the use of cumene hydroperoxide to probe isoenzyme specificity and regio-and stereoselectivity. Br J Clin Pharmacol 1990; 30: 751-60.
4. Masubuchi Y, Hosokawa S, Horie T, Suzuki T, Ohmori S, Kitada M, et al. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes: the role of CYP2D6 as ring hydroxylase and CYP1A2 as N-desisopropylase. Drug Metab Dispos 1994; 22: 909-15.
5. Yoshimoto K, Echizen H, Chiba K, Tani M, Ishizaki T. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers: N-desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol 1995; 39: 421-31.
6. Ching MS, Bichara N, Blake CL, Ghabrial H, Tukey RH, Smallwood RA. Propranolol 4-and 5-hydroxylation and N-desisopropylation by cloned human cytochrome P450 1A1 and P450 1A2. Drug Metab Dispos 1996; 24: 692-4.
7. Rowland K, Ellis SW, Lennard MS, Tucker GT. Variable contribution of CYP2D6 to the N-dealkylation of S-(-)-propranolol by human liver microsomes. Br J Clin Pharmacol 1996; 42: 390-3.
8. Adedoyin A, Prakash C, O'Shea D, Blair IA, Wilkinson GR. Stereoselective disposition of hexobarbital and its metabolites: relationship to the S-mephenytoin polymorphism in Caucasian and Chinese subjects. Pharmacogenetics 1994; 4: 27-38.
9. Walle T, Walle UK, Cowart TD, Conradi EC, Gaffney TE. Selective induction of propranolol metabolism by smoking: Additional effects on renal clearance of metabolites. J Pharmacol Exp Ther 1987; 241: 928-33.
10. Sesardic D, Boobis AR, Edwards RJ, Davies DS. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol 1988; 26; 363-72.
11. Xie HG, Huang SL, Zhou HH. High-performance liquid chromatographic determination of urinary 4′-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans. J Chromatogr B: Biomed Appl 1995; 668: 125-31.
12. Wedlund PJ, Sweetman BJ, McAllister CB, Branch RA, Wilkinson GR. Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography. J Chromatogr: Biomed Appl 1984; 307: 121-7.
13. de Morais SMF, Goldstein JA, Xie HG, Huang SL, Lu YQ, Xia H, et al. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther 1995; 58: 404-11.
14. Semple HA, Xia FM. Simplified high-performance liquid Chromatographic method for propranolol and five metabolites in liver perfusate, rat serum and dog plasma. J Chromatogr B: Biomed Appl 1994; 655: 293-9.
15. Xie HG, Chen X. Determination of propranolol in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection. Bull Hunan Med Univ 1991; 16: 193-5.